Business Wire

Der hier verfügbare Newsfeed wird von unserem Content-Partner Business Wire bereitgestellt. Es handelt sich dabei um einen der bedeutendsten und reichweitenstärksten Pressedienste, die Nachrichten, Pressemitteilungen und Multimedia-Inhalte an Medien, Journalisten und der Öffentlichkeit zur Verfügung stellen. Business Wire ist ein Tochterunternehmen des Warren-Buffett-Konzerns Berkshire Hathaway.
Der NewsWire-Hub ("X-Billboard") umfasst derzeit vfünf der wichtigsten internationalen Nachrichtenquellen und wird durch einen Börseninformationsservice ergänzt. Die einzelnen Newswire-Services ergänzen sich und bilden ein komplementäres Informationsangebot, mehr als drei Viertel der offiziellen Nachrichtenquellen ab, auf die sich Redaktionen weltweit bei ihrer Börsenberichterstattung stützen. Ihr Vorteil: Sie finden hier alles in einer Übersicht. Über die Steuerelemente können Sie zu den einzelnen Bereichen navigieren. Im Terminalview können Sie gezielt auf Unternehmensebene individuelle Recherchen durchführen.
presented by
H
More Tools & Gadgets
F&G: 63
6.454,98 S&P · 15,70 Vola-Index · 117.323,40 BTC · 1,17150 EURUSD
Systemstatus: 55.094 Nachrichten wurden bislang erfolgreich verarbeitet
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
Business Wire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
JP3111200006
Letzte Aktualisierung: 15.08.2025 | 5PM
Kennen Sie bereits den neuen Terminal-View? Folgen Sie bei Interesse dem folgenden Link.
FIGI: BBG000BFYC09
34070
Asahi Kasei Corporation
GICS: 15101010 · Sektor: Chemicals · Sub-Sektor: -
NAME
Asahi Kasei Corporation
ISIN
JP3111200006
TICKER
34070
MIC
XJPX
REUTERS
3407.T
BLOOMBERG
3407 JP
Do., 31.07.2025       Asahi Kasei
JP3111200006

Diversified global manufacturer Asahi Kasei and Toyota Tsusho have established a strategic partnership for the supply of automotive lithium-ion battery (LIB) separator in North America. Their respective subsidiaries in the U.S., Asahi Kasei Battery Separator America, LLC (AKBSA) and Toyota Tsusho America, Inc. (TAI), have finalized a capacity righ...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 30.07.2025       Asahi Kasei
JP3111200006

Diversified global manufacturer Asahi Kasei will supply its Aqualyzer™-C3 containerized 1 MW-class alkaline-water electrolyzer to the Central Finland Mobility Foundation (Cefmof). The system will play an essential role in Central Finland’s hydrogen production and contribute to the region’s decarbonization efforts. Full operation is expected to beg...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 29.07.2025       Asahi Kasei
JP3111200006

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova™ virus removal filters in Nobeoka City, Miyazaki, Japan. The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters. Construction is scheduled to begin ...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Silent Ad
Do., 17.07.2025       Asahi Kasei
JP3111200006

Japanese technology company Asahi Kasei has announced that its Microza & Water Processing Division, which provides Microza® hollow-fiber membranes for filtration and separation, received a Gold rating in the EcoVadis sustainability assessment conducted in June 2025. EcoVadis is a sustainability assessment company based in France that performs ...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 02.07.2025       Asahi Kasei
JP3111200006

Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomodulin™ Injection in Japan) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) related symptoms. This announcement follows encouraging data from earlier Phase I and II studies p...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 03.06.2025       Asahi Kasei
JP3111200006

Asahi Kasei has received the 2025 Imperial Invention Prize from the Japan Institute of Invention and Innovation, the highest award presented at the 2025 National Commendation for Invention. The formal award ceremony is scheduled to be held on July 1, 2025. The company was honored for its invention of a nickel-coated absorption layer, which extends...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 28.05.2025       Asahi Kasei
JP3111200006

Asahi Kasei has developed the TA Series of Sunfort™ dry film photoresist as a new product designed to meet growing demand in the field of advanced semiconductor packages used in applications such as artificial intelligence (AI) servers. This product is positioned as a strategic offering within Asahi Kasei's Material sector, aiming to strengthen it...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mo., 19.05.2025       Asahi Kasei
JP3111200006

Leading semiconductor manufacturer Asahi Kasei Microdevices (AKM) and Swedish digital audio pioneer Dirac have announced a partnership to integrate Dirac’s suite of software-defined smart acoustics solutions, AudioIQ, into AKM’s line of automotive audio digital signal processors (DSPs), including its flagship AK7709, to significantly reduce tuning...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 14.05.2025       Asahi Kasei
JP3111200006

Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have announced a strategic, exclusive partnership aimed at delivering a streamlined process to the peptide manufacturing industry. This collaboration establishes AKBA as the exclusive OEM for peptide synthesis columns to PeptiSystems, which carries out R&D, manufacturing, and supply of ins...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 13.05.2025       Asahi Kasei
JP3111200006

On March 25, Japanese technology company Asahi Kasei was awarded the prestigious Okochi Memorial Prize, which acknowledges significant contributions to the areas of production engineering, production technology R&D, and the implementation of high-level production methods in Japan. The Okochi Memorial Foundation recognized the contribution of A...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Silent Ad
Di., 06.05.2025       Asahi Kasei
JP3111200006

Asahi Kasei Microdevices (AKM) has developed the AP4413, a new series of ultra-low current power management ICs (PMICs) ideal for battery charging systems used in energy harvesting1 applications. The AP4413 series enables efficient battery charging while consuming an extremely low current of 52 nA and features four variants with voltage threshold ...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 29.04.2025       Asahi Kasei
JP3111200006

Asahi Kasei Microdevices Corporation (AKM) and Silicon Austria Labs GmbH (SAL) have successfully completed a joint proof of concept for integrating a current sensor into a power module to be used in automotive applications such as traction inverters and DC-DC converters. This technology enables energy efficiency, as well as compact and lightweight...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mo., 28.04.2025       Asahi Kasei
JP3111200006

Asahi Kasei Bioprocess America, Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the biopharmaceutical industry, has been recognized with the Best Technologies Innovation Award at INTERPHEX 2025. This recognition was for AKBA’s THESYS® Cleavage & Deprotection (C&D) and Tangential Flow Filtration (TFF) unit, a...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Do., 24.04.2025       Asahi Kasei
JP3111200006

Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector succeeding Richard Packer. Under Shinomiya, Asahi Kasei’s Healthcare Sector will further advance its portfolio and global presence of pharmaceuticals, life science, and critical care products and services. This press release featu...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 23.04.2025       Asahi Kasei
JP3111200006

Japanese technology company Asahi Kasei has started a joint demonstration with Nobian, Furuya Metal, and Mastermelt on the recycling of metals, including precious metals, used in the cells and electrodes incorporated in electrolyzers used for the production of caustic soda. Through this initiative started in February 2025, the partners will work t...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 08.04.2025       Asahi Kasei
JP3111200006

To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure. Through this change, the company can offer the industry more agile and focused services, deeper innovation in bioprocess solutions, and stronger support in emerging...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 04.03.2025       Asahi Kasei
JP3111200006

Bionova Scientific, an Asahi Kasei company and boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has announced the opening of a new facility in Fremont, California. The 55,000 sq. ft. process development and pilot plant will significantly expand the company’s ability to advance early-stage biologics as...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Di., 25.02.2025       Asahi Kasei
JP3111200006

Asahi Kasei and Kurashiki City held a grand opening ceremony on February 4, 2025, for a biogas purification system (the System) in Kurashiki, Okayama Prefecture, Japan. The System uses Asahi Kasei’s CO2 separation/recovery technology utilizing zeolites installed at a sewage treatment plant. The goal of this collaboration is to evaluate and demonst...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 15.01.2025       Asahi Kasei
JP3111200006

The Japanese technology company Asahi Kasei has received governmental support for the expansion of its manufacturing capacity for cell frames and membranes of alkaline water electrolyzers for the production of green hydrogen at its plant site in Kawasaki, Japan. The purpose is to establish a stable domestic manufacturing supply chain for technolog...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Mi., 11.12.2024       Asahi Kasei
JP3111200006

Asahi Kasei Pharma has taken another step in its transformation into a global specialty pharmaceuticals company through a new licensing agreement with Chiome Bioscience for its humanized anti-CX3CR1 antibody. The partnership exemplifies Asahi Kasei Pharma’s Open Innovation platform, which addresses unmet medical needs through strategic collaborati...
weiterlesen
Asahi Kasei
Research & Analysen Termsheet Terminal
Permalink
Silent Ad

Die hier zur Verfügung gestellten Informationen unterliegen keiner redaktionellen Bearbeitung. Die Aufbereitung erfolgt vollautomatisch und wird durch Zusatzinformationen und weiterführende Recherchemöglichkeiten angereichert. Ziel der Inhalte ist die schnelle und unkomplizierte Versorgung der Informationssuchenden mit den für sie relevanten Informationen. Durch eine Rückverlinkung auf den Informationsanbieter und -eigentümer ist sichergestellt, dass die hier aufbereiteten Daten bei Bedarf mit den Quellinformationen abgeglichen werden können. Das Newsboard zeigt keine Informationen in Echtzeit. Diese bitten wir bei Bedarf beim Börsenbetreiber abzurufen. Es besteht kein Anspruch auf Vollständigkeit. Hochverfügbarkeit kann nicht gewährleistet werden. Sollten Sie Fehler in der Funktionsweise bemerken, teilen Sie uns diese über das weiter unten befindliche Formular "Report a Bug" mit.

RAW DATA PROCESSING bedeutet, dass Rohdaten verarbeitet werden, ohne den Inhalt zu verändern. Um die Interpretation der Information im Sinne der Nutzbarkeit zu verbessern, werden die Daten ergänzt. 

Hinweis: Über das Newswire-Crosslink-Panel im oberen Bereich gelangen Sie schnell und bequem zu weiteren Informationsquellen. Im Terminalview sind die Nachrichten auf Unternehmensebene gefiltert und ermöglich darüber gezielte Recherchen.

Wir bedanken uns im Namen der Investoren-Community bei BusinessWire für die Bereitstellung der News- und Datenfeeds

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S